CMC- Chemo4METPANC

Gemcitabine, nab-paclitaxel, cemiplimab and motixafortide for first line treatment of stage 4 pancreatic cancer.
Status:

Open

Trial Type:
Pancreas Cancer

Contact:

Alex Raufi, MD
araufi2@brownhealth.org

©2024 Brown Cancer Clinical Trials